These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 22203607)

  • 21. A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.
    Bhattacharya S; Sobel JD; White TC
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5858-66. PubMed ID: 27431223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S; Rahkhoodaee F; Raymond M
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of
    Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H
    Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845
    [No Abstract]   [Full Text] [Related]  

  • 24. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
    Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the modulatory effect of magnesium on efflux mechanisms of Candida albicans reveal inhibition of ATP binding cassette multidrug transporters and dysfunctional mitochondria.
    Hans S; Fatima Z; Hameed S
    Biometals; 2021 Apr; 34(2):329-339. PubMed ID: 33394279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
    J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of activity and mechanisms of azole-bisphosphonate synergy in pathogenic
    Kane A; Dinh H; Campbell L; Cain AK; Hibbs D; Carter D
    Microbiol Spectr; 2024 Jun; 12(6):e0012124. PubMed ID: 38695556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism.
    Singh S; Fatima Z; Ahmad K; Hameed S
    PLoS One; 2018; 13(8):e0203079. PubMed ID: 30157240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
    Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a D-octapeptide derivative inhibitor.
    Niimi K; Harding DR; Holmes AR; Lamping E; Niimi M; Tyndall JD; Cannon RD; Monk BC
    Mol Microbiol; 2012 Aug; 85(4):747-67. PubMed ID: 22788839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
    FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
    Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
    Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
    Calabrese D; Bille J; Sanglard D
    Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic interactions between β-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans.
    Moraes DC; Reis de Sá LF; Domingos LTS; Pinto MDCFR; Soares RMA; Ferreira-Pereira A
    Rev Iberoam Micol; 2020; 37(3-4):104-106. PubMed ID: 33229297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the multi-drug efflux systems of pathogenic fungi using functional hyperexpression in Saccharomyces cerevisiae.
    Niimi M
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(2):79-86. PubMed ID: 20467195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3.
    Monod M; Feuermann M; Salamin K; Fratti M; Makino M; Alshahni MM; Makimura K; Yamada T
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.